Posted in | News | Optics and Photonics

Lockheed Martin Introduces Advanced Electro-Optical Targeting System for F-35 Lightning II Stealth Fighter

Today, Lockheed Martin introduced Advanced EOTS, an evolutionary electro-optical targeting system, which is available for the F-35's Block 4 development.

Designed to replace EOTS, the F-35's current electro-optical targeting system, Advanced EOTS incorporates a wide range of enhancements and upgrades, including short-wave infrared, high-definition television, an infrared marker and improved image detector resolution. These enhancements increase F-35 pilots' recognition and detection ranges, enabling greater overall targeting performance.

"In today's environment, threats to our warfighters continue to evolve," said Paul Lemmo, vice president of Fire Control/SOF CLSS at Lockheed Martin Missiles and Fire Control. "With significant capability and performance enhancements, Advanced EOTS ensures that F-35 pilots can stay ahead of these threats, detecting targets faster and at greater distances while remaining unseen."

Due to its similarity in shape and size to EOTS, Advanced EOTS can be installed with minimal changes to the F-35's interface. It will be housed behind the same low-drag window, maintaining the F-35's stealthy profile. Advanced EOTS production will be completed on the current EOTS line.

Advanced EOTS and EOTS are the first sensors to combine forward-looking infrared and infrared search and track functionality to provide precise air-to-air and air-to-ground targeting capability. Advanced EOTS was developed jointly through significant Lockheed Martin and supplier investment, with team members drawing on proven experience in electro-optical sensor design and manufacturing.

For additional information, visit our website: http://lockheedmartin.com/eots.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.